Literature DB >> 6150654

Ockelbo disease in Sweden: epidemiological, clinical, and virological data from the 1982 outbreak.

A Espmark, B Niklasson.   

Abstract

An outbreak of Ockelbo disease, a syndrome with rash, arthralgia and moderate fever reactions, which occurred in Sweden 1982 is described. A virus, designated Edsbyn 5/82, isolated from mosquitoes and closely related to Sindbis virus (Togaviridae: Alphavirus) is the probable etiologic agent. Sixty-five patients with typical clinical manifestations of the disease became ill in August 1982 and exhibited antibody titer rises against both Edsbyn 5/82 and Sindbis viruses by indirect immunofluorescence and the mixed hemadsorption technique. With the latter method, but not by the neutralization tests, antibody titers were significantly higher against Edsbyn 5/82 virus than against Sindbis virus. Most cases occurred in central Sweden between the 60th and 63rd parallels. The frequency of antibody in healthy individuals (blood donors) within the endemic area was 2-3% and in foci with high incidence, antibody positivity reached 8%. Antibody frequencies continuously decreased south and north of this area. Antibody decline was followed in a group of 12 patients who had Ockelbo disease in 1981. Mixed hemadsorption titers were 4-6 times higher against Edsbyn 5/82 than against Sindbis virus. A 2- to 4-fold antibody decline took place from early convalescence to 20 months after onset.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6150654     DOI: 10.4269/ajtmh.1984.33.1203

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  14 in total

1.  Geographical and temporal distribution of Ockelbo disease in Sweden.

Authors:  J O Lundström; S Vene; A Espmark; M Engvall; B Niklasson
Journal:  Epidemiol Infect       Date:  1991-06       Impact factor: 2.451

2.  Possible ecology and epidemiology of medically important mosquito-borne arboviruses in Great Britain.

Authors:  J M Medlock; K R Snow; S Leach
Journal:  Epidemiol Infect       Date:  2006-08-08       Impact factor: 2.451

3.  Pathogenesis of encephalitis induced in newborn mice by virulent and avirulent strains of Sindbis virus.

Authors:  L A Sherman; D E Griffin
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

Review 4.  Age has a role in driving host immunopathological response to alphavirus infection.

Authors:  Yi-Hao Chan; Lisa F P Ng
Journal:  Immunology       Date:  2017-08-23       Impact factor: 7.397

5.  Development of specific antibody patterns and clinical symptoms following Ockelbo virus infection.

Authors:  S Vene; C Franzén; B Niklasson
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

Review 6.  Impact of climate change and other factors on emerging arbovirus diseases.

Authors:  E A Gould; S Higgs
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-09-16       Impact factor: 2.184

7.  Effect of host cell lipid metabolism on alphavirus replication, virion morphogenesis, and infectivity.

Authors:  Ching G Ng; Isabelle Coppens; Dhanasekaran Govindarajan; John Pisciotta; Vladimir Shulaev; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-09       Impact factor: 11.205

8.  Sindbis virus infection in resident birds, migratory birds, and humans, Finland.

Authors:  Satu Kurkela; Osmo Rätti; Eili Huhtamo; Nathalie Y Uzcátegui; J Pekka Nuorti; Juha Laakkonen; Tytti Manni; Pekka Helle; Antti Vaheri; Olli Vapalahti
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

9.  Family cluster of Mayaro fever, Venezuela.

Authors:  Jaime R Torres; Kevin L Russell; Clovis Vasquez; Roberto Barrera; Robert B Tesh; Rosalba Salas; Douglas M Watts
Journal:  Emerg Infect Dis       Date:  2004-07       Impact factor: 6.883

Review 10.  The Role of Culex pipiens L. (Diptera: Culicidae) in Virus Transmission in Europe.

Authors:  Victor A Brugman; Luis M Hernández-Triana; Jolyon M Medlock; Anthony R Fooks; Simon Carpenter; Nicholas Johnson
Journal:  Int J Environ Res Public Health       Date:  2018-02-23       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.